Mar 09, 2022 06:48 PM (GMT+8) · EqualOcean
According to the Internet, Pfizer, a pharmaceutical giant, suddenly submitted form No. 25 to the securities and Exchange Commission (SEC) and made a delisting application, saying that the delisting application was related to its vaccine business. Regarding the authenticity of the news, Pfizer China related person said: at present, we have not received any relevant information. However, the current document on the SEC's official website does not indicate that Pfizer has submitted a delisting application. That document only states that the entire class of securities called "17 CFR 240.12d2-2 (a) (2)" will be redeemed or paid upon expiration or retirement on March 7, 2022, not ordinary shares. In this regard, Pfizer China confirmed that the content is true.